As the temperature rises and the pool beckons, grab your copy of Annals of Allergy, Asthma & Immunology and catch up on the latest in allergy/immunology medical care. You might not realize just how up to date Annals articles are.
This past year Annals had the second highest Immediacy Index of all allergy journals – that means that papers published in Annals in 2024 were more likely to be cited in 2024 than those in almost all other allergy journals (Journal of Allergy and Clinical Immunology (JACI) was the only journal ahead of Annals). In terms of immunology journals, Annals had the seventh highest Immediacy Index (behind Immunity, Annual Review of Immunology, Lancet HIV, JACI, Nature Reviews Immunology, and Science Immunology). If that doesn’t convince you of the impact of articles in Annals, consider this – Annals had the fourth highest number of citations of all allergy journals, even though we publish between a half to a third of the number of pages as the other journals.
This month the focus is on an update of rhinitis. What is new in rhinitis, you ask? The CME Review this month explores the evolving treatment paradigms. Two editorials explore what to do when nasal steroids fail, and the role of alternative, complementary, and integrative medicine in allergic rhinitis. Have you thought about combining biologics in your armamentarium? A review this month explores outcomes and safety of combination biologic therapy. Our Master Clinician Series details how an expert treats mast cell activation syndrome.
As always, these impactful articles are available on our website in easily accessible collections that make it possible to use these articles when you are seeing patients. It’s one more way Annals helps you provide the best care possible to your patients!
Original articles this month include those that explore factors associated with severe asthma, the role of the peripheral blood eosinophil count as a biomarker for asthma exacerbation severity, and whether artificial intelligence can be used to provide education for oral immunotherapy. Also, this month there is a manuscript that details the development and validation of a pediatric food allergy anaphylaxis management plan, as well as one that explores the use of grocery-sourced real food solutions for sublingual immunotherapy of food allergies. And not to be forgotten is the new board game of “Allergy Shots” as detailed in this month’s Marginal Zone.
Annals strives to be your go-to journal for the most up-to-date information on allergy and immunology care, so that you can provide the best possible care to your patients. If you have any comments about the high-quality research published in the journal, please do not hesitate to email Annals (annals@ACAAI.org) and let us know your thoughts!
Mitchell H. Grayson, MD, FACAAI
Editor-in-Chief
